Navigation

LIVER DISEASE

â€¹Return to Previous Page

The endocannabinoid system and liver diseases (PubMed)
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (PubMed)
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis (PubMed)
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (PubMed)
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol (PubMed)
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (PubMed)
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation(PubMed)

Mobile version: Enabled

Back to top